Hotchkiss, Richard S.
Colston, Elizabeth
Yende, Sachin
Crouser, Elliott D.
Martin, Greg S.
Albertson, Timothy
Bartz, Raquel R.
Brakenridge, Scott C.
Delano, Matthew J.
Park, Pauline K.
Donnino, Michael W.
Tidswell, Mark
Mayr, Florian B.
Angus, Derek C.
Coopersmith, Craig M.
Moldawer, Lyle L.
Catlett, Ian M.
Girgis, Ihab G.
Ye, June
Grasela, Dennis M.
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Received: 3 May 2019
Accepted: 17 July 2019
First Online: 1 October 2019
Compliance with ethical standards
:
: EC, JY, IMC, IGG, and DMG are Bristol-Myers Squibb employees; EC, IMC, and DMG are Bristol-Myers Squibb shareholders. RSH receives research grant support and serves on advisory boards for Bristol-Myers Squibb. SY received grant support from Bristol-Myers Squibb for the design of this study. GSM reports grant support provided to Emory University from Bristol Myers Squibb for the conduct of the study. PKP’s institution received funding from the National Institutes of Health (NIH) and other support from the U.S. Food and Drug Administration/Biomedical Advanced Research and Development Authority, Atox Bio, and the Marcus Foundation. MWD receives funding from the NIH, American Heart Association, Open Philanthropy Project, General Electric, and Kaneka. DCA received consulting fees from Bristol-Myers Squibb for advice on study design. The remaining authors (LLM, EDC, TA, CMC, SCB, MT, FBM, RRB, and MJD) declare that they have no conflict of interest.
: BMS policy on data sharing may be found at:ExternalRef removed.